|
Sl. No. |
Name |
Strength |
Unit |
Manufacturer & Marketing Company |
Retail |
|
(1) |
(2) |
(3) |
(4) |
(5) |
(6) |
|
1. |
Clopidogrel Bisulphate + Aspirin Tablet |
Each uncoated bilayered tablet contains: Clopidogrel Bisulphate IP Eq. to Clopidogrel 75 mg Aspirin IP 75 mg |
1 Tablet |
M/s Akums Drugs & Pharmaceuticals Limited/ M/s Mylan Limited |
3.71 |
|
2. |
Glimepiride + Metformin Hydrochloride Tablet |
Each uncoated bilayered tablet contains: Glimepiride IP |
1 Tablet |
M/s Akums Drugs and Pharmaceuticals Ltd./M/s Emcure |
8.94 |
|
3. |
Glimepiride + Metformin Hydrochloride Tablet |
Each uncoated bilayered tablet contains: Glimepiride IP |
1 Tablet |
M/s Akums Drugs and Pharmaceuticals Ltd./M/s Emcure |
9.56 |
|
4. |
Atorvastatin + Aspirin Capsule |
Each Hard Gelatin Capsule contains:
Atorvastatin Calcium IP eq. Atorvastatin 10 mg (as Film Aspirin IP 75mg (as Gastro Resistant Tablet IP) |
1 Capsule |
M/s Micro Labs Limited |
2.42 |
|
5. |
Atorvastatin + Aspirin Capsule |
Each Hard Gelatin Capsule contains: Atorvastatin Calcium IP
Aspirin IP 150mg (as two Gastro Resistant Tablet IP each |
1 Capsule |
M/s Micro Labs Limited |
2.54 |
|
6. |
Cilnidipine + Telmisartan Tablet (Telsartan –LN 80) |
Each film coated tablet contains: Cilnidipine IP 10 mg, |
1 Tablet |
M/s Pure and Cure Healthcare Pvt. Ltd./ Dr. Reddy’s |
13.12 |
|
7. |
Cilnidipine + Telmisartan Tablet (Telsartan –LN 40) |
Each film coated tablet contains: Cilnidipine IP 10 mg, Telmisartan IP 40 mg |
1 Tablet |
M/s Pure and Cure Healthcare Pvt. Ltd./ Dr. Reddy’s |
8.65 |
|
8. |
Rosuvastatin + Aspirin + Clopidogrel Capsule (Rozat Gold 10mg) |
Each hard gelatin capsule contains: Rosuvastatin Calcium IP
Aspirin IP 75mg (As Aspirin Gastro-Resistant Tablets IP) |
1 Capsule |
M/s Akums Drugs and Pharmaceuticals Ltd / Dr. Reddy’s |
11.48 |
|
9. |
Rosuvastatin + Aspirin + Clopidogrel Capsule (Rozat Gold 20mg) |
Each hard gelatin capsule contains: Rosuvastatin Calcium IP
Aspirin IP 75mg (As Aspirin Gastro-Resistant Tablets IP) |
1 Capsule |
M/s Akums Drugs and Pharmaceuticals Ltd / Dr. Reddy’s |
17.46 |
|
10. |
Glimepiride + Metformin Hydrochloride Tablet (Glimy M3 |
Each uncoated bilayered tablet contains:
Glimepiride IP 3mg, Metformin Hydrochloride IP 1000mg(as |
1 Tablet |
M/s Akums Drugs and Pharmaceuticals Ltd/ Dr. Reddy’s |
8.94 |
|
11. |
Glimepiride + Metformin Hydrochloride Tablet (Glimy M4 |
Each uncoated bilayered tablet contains:
Glimepiride IP 4mg, Metformin Hydrochloride IP 1000mg(as |
1 Tablet |
M/s Akums Drugs and Pharmaceuticals Ltd / Dr. Reddy’s |
9.56 |
|
12. |
Etoricoxib + Paracetamol Tablet |
Each film coated tablet contains: Etoricoxib IP 60mg, |
1 Tablet |
M/s Pure and Cure Healthcare Pvt. Ltd. / M/s Zuventus |
5.58 |
|
13. |
Tolperisone Hydrochloride + Diclofenac Sodium Tablet |
Each film coated bilayered tablet contains: Tolperisone Hydrochloride IP 150mg, Diclofenac Sodium IP 50mg |
1 Tablet |
M/s Pure and Cure Healthcare Pvt. Ltd. / M/s Zuventus |
13.42 |
|
14. |
Cilnidipine + Metoprolol Tablet |
Each film coated bilayered tablet contains: Cilnidipine IP Tartrate 25mg (in extended release form) |
1 Tablet |
M/s Pure and Cure Healthcare Pvt. Ltd. /M/s Intas |
7.11 |
- (a) The manufacturer of above mentioned formulations i.e. ―new drug‖ under paragraph 2(u) of the DPCO, 2013 shall fix the retail price as specified in column (6) of the table hereinabove.
- (b) The manufacturer may add goods and services tax only if they have paid actually or it is payable to the Government on the retail price mentioned in column (6) of the above said table.
- (c) The retail price for a pack of the aforesaid formulation shall be arrived at by the concerned manufacturer in accordance with the retail price specified in column (6) of the above table as per provisions contained in paragraph 11 of the DPCO, 2013. The manufacturer shall issue a price list in Form–V from date of Notification as per paragraph 24 of the DPCO, 2013 to NPPA through IPDMS and submit a copy to State Drug Controller and dealers.
- (d) As per para 24(4) of DPCO 2013, every retailer and dealer shall display price list and the supplementary price list, if any, as furnished by the manufacturer, on a conspicuous part of the premises where he carries on business in a manner so as to be easily accessible to any person wishing to consult the same.
- (e) The above mentioned retail price is applicable only to the individual manufacturer / marketer as mentioned above i.e. who have applied for the same by submitting Form-I for price fixation / revision as stipulated under DPCO, 2013 and subject to fulfilment of all the applicable statutory requirements as laid down by the Govt. under relevant statutes/ rules, including manufacturing license permission from the Competent Authority i.e. the Central/State Licensing Authority, as may be applicable, by the concerned manufacturer/marketing companies.
- (f) In case the retail price of any of the aforesaid formulations is not complied with, as per instant price notification and notes specified hereinabove, then the concerned manufacturer/marketing company shall be liable to deposit the overcharged amount along with the interest thereon under the provisions of the DPCO, 2013 read with the Essential Commodities Act, 1955.
- (g) Consequent to the issue of ceiling price of such formulation as specified in column (2) of the above table in this notification, the price order(s) fixing ceiling or retail price, if any, issued prior to the above said date of notification, stand(s) superseded.